tiprankstipranks
Synairgen PLC (GB:SNG)
LSE:SNG
Holding GB:SNG?
Track your performance easily

Synairgen (SNG) Share Price & Analysis

15 Followers

SNG Stock Chart & Stats


Financials

Annual

SNG FAQ

What was Synairgen PLC’s price range in the past 12 months?
Synairgen PLC lowest share price was 3.00p and its highest was 10.00p in the past 12 months.
    What is Synairgen PLC’s market cap?
    Currently, no data Available
    When is Synairgen PLC’s upcoming earnings report date?
    Synairgen PLC’s upcoming earnings report date is Mar 13, 2025 which is in 76 days.
      How were Synairgen PLC’s earnings last quarter?
      Synairgen PLC released its earnings results on Sep 26, 2024. The company reported -0.016p earnings per share for the quarter, missing the consensus estimate of N/A by -0.016p.
        Is Synairgen PLC overvalued?
        According to Wall Street analysts Synairgen PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Synairgen PLC pay dividends?
          Synairgen PLC does not currently pay dividends.
          What is Synairgen PLC’s EPS estimate?
          Synairgen PLC’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Synairgen PLC have?
          Synairgen PLC has 202,660,690 shares outstanding.
            What happened to Synairgen PLC’s price movement after its last earnings report?
            Synairgen PLC reported an EPS of -0.016p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.794%.
              Which hedge fund is a major shareholder of Synairgen PLC?
              Currently, no hedge funds are holding shares in GB:SNG
              ---

              Company Description

              Synairgen PLC

              Synairgen PLC is a United Kingdom-based respiratory drug discovery and development company. The company is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in the areas, including severe asthma, kidney fibrosis, cardiac fibrosis, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The company's Programmes include SNG001, SG016, LOXL2 inhibitor, and others.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Avacta Group plc
              Open Orphan Plc
              ANGLE plc
              PureTech Health
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis